Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
These are used for people with type 2 diabetes or to help with losing weight
A new computational intelligence approach to detect autistic features for autism screening
Confirm availability with customer service
Novo Nordisk leads the sector in spending on shareholder enrichment: With a ratio of 1.41, Novo Nordisk spent 41% more on shareholder returns (buybacks and dividends) compared to R&D, making it the highest spender on shareholder enrichment among 15 peer companies 9 in the pharmaceutical sector
Compare Sermorelin by mechanism, evidence strength, expected timeline, side-effect profile, and whether its primary use case matches your goal
(see label)
US$ 20.88
US$ 25.38
US$ 27.23
US$ 21.81
